'Shouldn't jump to conclusions until completion', Adar Poonawalla says as Oxford resumes COVID vaccine trials

Just as biopharmaceutical giant AstraZeneca and the University of Oxford on Saturday announced that clinical trials for their coronavirus vaccine have resumed in the UK, Adar Poonawalla advised all to not jump to conclusions until completion of the process. Poonawalla is the chief executive officer of the vaccine's local manufacturer Serum Institute of India (SII).

from IndiaTV India: Google News Feed https://ift.tt/3kdw3Kg
via